CXCL12 and breast cancer: The metastasis of breast cancer cells to lymph nodes, lungs, liver, and bone marrow is inhibited by neutralizing the interaction of cognate ligand CXCL12 (SDF-1) with its overexpressed chemokine receptor CXCR4.